Introduction: eligibility recommendations for competitive athletes with cardiovascular abnormalities-general considerations.

[1]  Michael J Ackerman,et al.  Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. , 2004, Circulation.

[2]  Maurizio Schiavon,et al.  Does sports activity enhance the risk of sudden death in adolescents and young adults? , 2003, Journal of the American College of Cardiology.

[3]  B. Maron Sudden death in young athletes. , 2003, New England Journal of Medicine.

[4]  B. Maron,et al.  Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy. , 2003, Journal of the American College of Cardiology.

[5]  M. Link,et al.  Clinical profile and spectrum of commotio cordis. , 2002, JAMA.

[6]  H. Hecht Recommendations for preparticipation screening and the assessment of cardiovascular disease in masters athletes. , 2001, Circulation.

[7]  M. Link,et al.  Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. , 2000, The New England journal of medicine.

[8]  B. Maron,et al.  Prevalence of sudden cardiac death during competitive sports activities in Minnesota high school athletes. , 1998, Journal of the American College of Cardiology.

[9]  B. Maron,et al.  Competitive athletes with cardiovascular disease--the case of Nicholas Knapp. , 1998, The New England journal of medicine.

[10]  F O Mueller,et al.  Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. , 1996, JAMA.

[11]  F O Mueller,et al.  Blunt impact to the chest leading to sudden death from cardiac arrest during sports activities. , 1995, The New England journal of medicine.

[12]  B. Maron,et al.  Legal considerations that affect medical eligibility for competitive athletes with cardiovascular abnormalities and acceptance of Bethesda Conference recommendations. , 1994, Medicine & Science in Sports & Exercise.

[13]  P. Raven 26th Bethesda Conference , 1994 .

[14]  B. Maron,et al.  Ethical, legal and practical considerations affecting medical decision-making in competitive athletes. , 1994, Journal of the American College of Cardiology.

[15]  B. Maron,et al.  26th Bethesda Conferance: Recommendations for determining eligibility for competetion in athletes with cardiovascular abnormalities , 1994 .

[16]  B. Maron Sudden death in young athletes. Lessons from the Hank Gathers affair. , 1993, The New England journal of medicine.

[17]  J E Smialek,et al.  Sports-related and non-sports-related sudden cardiac death in young adults. , 1991, American heart journal.

[18]  J. Mitchell,et al.  16th Bethesda Conference: Cardiovascular abnormalities in the athlete: recommendations regarding eligibility for competition. October 3-5, 1984. , 1985, Journal of the American College of Cardiology.

[19]  B. Maron Hypertrophic cardiomyopathy: an important global disease. , 2004, The American journal of medicine.

[20]  M. Mitten Enhanced Risk of Harm to One's Self as a Justification for Exclusion from Athletics , 1998 .

[21]  M. Mitten Team Physicians and Competitive Athletes: Allocating Legal Responsibility for Athletic Injuries , 1993 .